Alnylam Pharmaceuticals
John Vest serves as the Senior Vice President of Clinical Research at Alnylam Pharmaceuticals, where a diverse background in clinical development is evident from previous roles including Vice President and Executive Director. Prior experience at Novartis involved pivotal contributions to cardiovascular discovery and drug development strategies. Academic credentials include a Doctor of Medicine from Columbia University and a Bachelor of Arts from Harvard University. Clinical expertise was refined through positions as an Assistant Professor of Clinical Medicine at Columbia University and fellowships at Brigham and Women's Hospital and New York Presbyterian Hospital, where leadership in Cardiology and internal medicine has been demonstrated.
Alnylam Pharmaceuticals
32 followers
Alnylam is the world's leading RNAi therapeutics company and the first and only company to bring an RNAi medicine to market.